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Skeletal muscle physiology is influenced by the presence of chemically reactive
molecules such as reactive oxygen species (ROS). These molecules regulate multiple
redox-sensitive signaling pathways that play a critical role in cellular processes including
gene expression and protein modification. While ROS have gained much attention for
their harmful effects in muscle fatigue and dysfunction, research has also shown ROS
to facilitate muscle adaptation after stressors such as physical exercise. This manuscript
aims to provide a comprehensive review of the current understanding of redox signaling
in skeletal muscle. ROS-induced oxidative stress and its role in the aging process are
discussed. Mitochondria have been shown to generate large amounts of ROS during
muscular contractions, and thus are susceptible to oxidative stress. ROS can modify
proteins located in the mitochondrial membrane leading to cell death and osmotic
swelling. ROS also contribute to the necrosis and inflammation of muscle fibers that
is associated with muscular diseases including Duchenne muscular dystrophy. It is
imperative that future research continues to investigate the exact role of ROS in normal
skeletal muscle function as well as muscular dysfunction and disease.
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INTRODUCTION
Current research is revealing new perspectives regarding the biological significance of free radicals
and other chemically reactive molecules in numerous physiological processes and pathological
conditions. Reactive oxygen species (ROS), when generated in excess amounts, contribute to
oxidative stress. ROS produced from contracting skeletal muscle are known to affect both muscle
adaption and function (Zuo et al., 2011a, 2013). However, these species, at optimal levels, can
be critical for biological function. For instance, ROS have functional roles in innate and adaptive
immunity, as well as initiating secondary signal transduction processes (Daiber, 2010; Nathan and
Cunningham-Bussel, 2013; Zuo et al., 2014c). ROS can also cause structural and functional damage
through lipid oxidation, and modification of proteins and DNA (Lobo et al., 2010). The increase
of ROS has been considered a significant factor in the aging process as ROS contribute heavily to
cellular oxidative stress, associated with aging (Hensley and Floyd, 2002; Liochev, 2013). Other
potential effects exerted by ROS may include DNA damage, decreased mitochondria function,
dysfunctional polypeptides, reduced muscle contractile force, and loss of muscle mass (Brandes
et al., 2005; Shi et al., 2013). Particularly, ROS play an important role in the functioning of skeletal
muscle (Zuo et al., 2013, 2015a), since ROS may mediate adaptive responses by facilitating glucose
uptake or inducing mitochondrial biogenesis (Merry et al., 2010; Powers et al., 2011). On the
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other hand, research has also shown ROS to promote muscle
fatigue and contribute tomuscle dysfunction involved in a variety
of chronic diseases (Reid and Moylan, 2011; Zuo et al., 2012).
ROS/RNS IN SKELETAL MUSCLE
Sustained contractile activity of muscle fibers can result in
inflammation, altered hormonal environments, and an increase
in the production of ROS and other free radicals (Fittipaldi
et al., 2014). Among these reactive molecules, nitric oxide (NO•)
can be produced within skeletal muscle fibers from L-arginine
by NO• synthase (NOS). Three major isoforms of NOS exist:
neuronal NOS (nNOS or NOS I); inducible NOS (iNOS or
NOS II); and endothelial NOS (eNOS or NOS III) (Stamler and
Meissner, 2001). NO• production is vital for the mediation of
signaling pathways during muscle contractions (Figure 1). For
example, NO• has been implicated in both the activation and
inhibition of ryanodine receptors (RyR) (Hart and Dulhunty,
2000; Stamler and Meissner, 2001). RyR are redox sensitive
channels that facilitate the rapid release of Ca2+ into the cytosol,
which is critical for excitation-contraction coupling (Stamler and
Meissner, 2001; Zalk et al., 2015). Hirschfield et al. reported that
FIGURE 1 | Schematic illustrating the effects of ROS generated from skeletal muscle contractions. NO, nitric oxide; ROS, reactive oxygen species;
ONOO−, peroxynitrite; MAPK, mitogen-activated protein kinase; PGC-1α, proliferator-activated receptor-γ coactivator-1α; AMPK, 5′ adenosine
monophosphate-activated protein kinase; GLUT4, glucose transporter type 4; CaMK, Ca2+/calmodulin-dependent kinase.
NO• release increased eight-fold during active contractions in
mouse diaphragmatic skeletal muscle (Hirschfield et al., 2000).
Interestingly, this study also revealed neither NO• release rates
nor contractile function were affected in NOS III-deficient mice,
suggesting that NOS III is not involved in muscle contractions
(Hirschfield et al., 2000). This was unexpected given that NOS
I and III are generally believed to be constitutively expressed
in skeletal muscle (Hirschfield et al., 2000; Fleming, 2010).
Further research may be required to explain the physiological
relevance of NOS III in skeletal muscle. NOS I is found to be
expressed in type II (fast-twitch) muscle fibers and is primarily
located around the sarcolemma (Kobzik et al., 1994; Hart and
Dulhunty, 2000). NOS II has been observed to be a marked
source of NO• production during immunological defense and
inflammatory responses (Weinberg, 2000; Fleming, 2010). NO•
inhibition is associated with several disorders such as diabetes
and hypertension (Cai and Harrison, 2000). One mechanism
of NO inactivation is the reaction of NO• with O•−2 that
produces peroxynitrite (ONOO−), which is a potent oxidizing
agent (Figure 1) (Hayashi et al., 2004; Sindler et al., 2009). The
negative effects of such a reaction are compounded because of the
increased levels of ROS and the corresponding NO• deficiency.
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Muscle contractions stimulate O•−2 formation through
activation of NADPH oxidase (NOX) (Jackson, 2008), xanthine
oxidase (XO) (Duncan et al., 2005; Gomez-Cabrera et al., 2010;
Barbieri and Sestili, 2012), and several mitochondrial respiratory
complexes and enzymes (Turrens, 2003). O•−2 can be further
reduced to hydrogen peroxide (H2O2) via superoxide dismutases
(SOD). However, H2O2 can, in turn, form highly reactive
hydroxyl radicals (•OH) through a Fenton reaction (Thomas
et al., 2009; Kothari et al., 2010). The newly formed •OH
chemically reacts with essential biological macromolecules such
as carbohydrates, protein, and lipids leading to adverse functional
alterations that are often irreversible (Wu and Cederbaum, 2003;
Brieger et al., 2012).
AMPK AND ROS SIGNALING
In skeletal muscle, ROS/RNS can play an important role in
the regulation of glucose metabolism by activating the 5′
adenosine monophosphate-activated protein kinase (AMPK)
pathway. ONOO− can activate the muscular AMPK pathway
and increase glucose metabolism (Xie et al., 2006). Additionally,
stressors, such as hypoxia, may stimulate AMPK activation in
order to produce ATP (Xie et al., 2006). AMPK is involved
in the insulin-dependent translocation of glucose transporter
type 4 (GLUT4), and consequently increases glucose uptake
by myocytes (Figure 1). AMPK signaling also leads to ATP
generation by the inhibition of acetyl-coenzyme A (CoA)
carboxylase (ACC) (Chen et al., 2000; Schroeder et al., 2009;
Wakil and Abu-Elheiga, 2009).
Increases in ROS production are generated through a variety
of signaling mechanisms. For example, interleukin (IL)-13 plays
a critical role in the immune system maintaining normal
homeostasis as well as responding to pathogens (Mandal et al.,
2010). IL-13 stimulates ROS as secondary messengers via janus
kinase (JAK) signal transducer and activator of transcription
(STAT) pathways (Mandal et al., 2010). IL-13 employs the
MEK/ERK pathway to facilitate ROS production (Mandal
et al., 2010). ROS also activate proliferator-activated receptor-γ
coactivator-1α (PGC-1α) (via AMPK), nuclear factor κB (NF-
κB), ERK 1/2, and p38 MAPK pathways (Irrcher et al., 2009;
Mandal et al., 2010; Morris et al., 2013).
Increased ROS levels induce oxidative modification to
the Met281/282 pair located in the regulatory domain of
Ca2+/calmodulin-dependent kinase II (CaMKII) (Erickson et al.,
2008, 2011). This suggests that ROS may indirectly have a
role in skeletal muscle’s ability to adapt to environmental
stressors. Furthermore, ROS are involved in initiating the
classical MAPK signaling cascade. The MAPK family inhibits or
activates numerous signaling pathways through phosphorylation
of regulatory proteins. This is a well-established mechanism
by which cellular ROS levels induce skeletal muscle adaptation
(Figure 1) (Cuschieri and Maier, 2005; Powers et al., 2010).
Interestingly, when untrained athletes begin intensive
training, their immunological state is compromised due in
part to the mitigation of neutrophilic ROS (Koga et al., 2013).
ROS are also involved in angiotensin II-mediated physiological
responses including interruption of endothelium-dependent
vasodilation (Griendling and Ushio-Fukai, 2000). ROS mediated
cell apoptosis is associated with the serine/threonine protein
kinase mammalian target of rapamycin (mTOR) activity. The
mTOR complexes can maintain cell homeostasis against stressors
such as nutrient loss or growth factor deprivation. Dysregulation
of mTOR activity impedes the cell’s defense mechanism
against growth factor deprivation, leading to endoplasmic
reticulum stress (Sengupta et al., 2010), and apoptosis through
overproduction of ROS (Ozcan et al., 2008; Di Nardo et al.,
2009).
MUSCLE ADAPTATION AND ATROPHY
ROS are known to be key mediators in redox signaling
pathways stimulating cellular proliferation, growth, and
differentiation (Ji, 2008). ROS generated during skeletal muscle
contractions have been demonstrated to be critical to cell
functionality (Ji, 2008; Barbieri and Sestili, 2012). Furthermore,
the activity of factors such as nuclear factor of activated T-cells
(NFAT), Ca2+/calmodulin-dependent kinase II (CaMKII) (the
predominant CaMK isoform present in human skeletal muscle),
and calcineurin all play a marked role in adaptation to events
including exercise training (Chin, 2005; Erickson et al., 2011;
Barbieri and Sestili, 2012; Ojuka et al., 2012). For example,
the activation of CaMK is involved in the increase of glucose
transport activity via GLUT4 translocation during contractile
activity (Figure 1) (Wright et al., 2004; Hawley et al., 2006; Egan
and Zierath, 2013). The inhibition of CaMK significantly reduces
glucose uptake in vitro (Hawley et al., 2006).
ROS trigger pathways that result in skeletal muscle
remodeling and protein synthesis (Powers et al., 2010).
Skeletal muscle remodeling serves as an adaptive response
that enables the muscle to accommodate physiological changes
(Bassel-Duby and Olson, 2006). ROS production is necessary for
the remodeling of skeletal muscle in strenuous exercise (Barbieri
and Sestili, 2012). Indeed, research has indicated that increased
ROS production is a necessary response to exercise of a sufficient
intensity (Vollaard et al., 2005). However, there is also evidence
that ROS are involved in skeletal muscle damage and dysfunction
after intense or unaccustomed exercise (Close et al., 2004). One
study investigated the effects of manganese SOD (Mn-SOD)
deficiency in mice and found that these mice were functionally
impaired during intense, but not mild, exercise (Kuwahara et al.,
2010). Mn-SOD serves as protection for the mitochondrial
matrix by converting O•−2 into H2O2. However, skeletal muscle
atrophy was not found to be a consequence of minimized
Mn-SOD activity (Kuwahara et al., 2010; Lustgarten et al., 2011).
Disrupted ROS homeostasis in the myoplasm is proposed to be a
central cause of muscle fatigue (Kuwahara et al., 2010). Moderate
exercise is not associated with the oxidative stress-induced
damage in the same way as exhaustive exercise (Gomez-Cabrera
et al., 2008). Instead, it is believed that moderate, regular
exercise stimulates optimal ROS production that upregulates
the expression of antioxidant defense systems (Gomez-Cabrera
et al., 2008). Regular exercise reduces a person’s risk for oxidative
stress-related cardiovascular diseases, cancer, or stroke (Radak
et al., 2005). Therefore, moderate levels of oxidant production,
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TABLE 1 | Detrimental effects of ROS in skeletal muscle.
Process Mechanism Effect References
Aging myocytes Oxidation of mtDNA • Reduced capability of mitochondria to
produce cellular energy
Picard et al., 2014
mPTP opening • Mitochondrial swelling
• Escape of proapoptotic proteins
• Apoptotic or necrotic cell death
Lemasters et al., 2009;
Barbieri and Sestili, 2012
AIF and Endo G release • DNA fragmentation Barbieri and Sestili, 2012
Induced activity of proteases and nucleases • Apoptosis Cadenas and Davies, 2000
Skeletal muscle contraction Activation of calpains and caspases • Myofibrillar protein degradation Ochala et al., 2011
Nitrosylation of RyR1 receptor • Increase the leakiness of sarcoplasmic
reticulum Ca2+
Bellinger et al., 2009;
Westerblad and Allen, 2011
Oxidation of sarcolemmal lipids or contractile
proteins
• Muscle dysfunction Goldstein and Mcnally, 2010
Neuromuscular function SOD1 deficiency • Motor axon degeneration Fischer et al., 2011, 2012
Chronic muscle disuse Decreased mitochondrial content; increased
ROS production and apoptosis signaling
• Muscle atrophy and weakness Adhihetty et al., 2007
AIF, apoptosis inducing factor; Endo G, mitochondrial endonuclease G; mPTP, mitochondrial permeability transition pore; mtDNA, mitochondrial DNA; SOD1, Cu, Zn-superoxide
dismutase.
as a result of exercise, may confer biological protection (Radak
et al., 2005; Gomez-Cabrera et al., 2008). Alternatively, during
extended periods of disuse, redox imbalances contribute to
deleterious skeletal muscle remodeling (e.g., atrophy) via
myonuclear apoptosis and muscle atrophy (Powers et al., 2010).
Interestingly, NF-κB, a redox sensitive transcription factor, may
regulate as many as 150 genes during muscle adaptation in
response to inactivity or exercise (Sun et al., 2002; Bassel-Duby
and Olson, 2006; Powers et al., 2010). One study investigated
the activity of pathways that respond to chronic muscle disuse
induced by denervation. Increased ROS production played a
large role in mediating muscle atrophy and weakness, lowering
mitochondrial content, and increasing apoptosis signaling
(Table 1) (Adhihetty et al., 2007). A different study reported a
30-fold increase in mitochondrial ROS production 7 days after
denervation in skeletal muscle (Muller et al., 2007). This finding
corroborated a strong correlation between muscle atrophy
and ROS production. Apoptosis also contributes to muscle
degeneration during normal aging and pathological conditions
(Adhihetty et al., 2007). For instance, skeletal muscle atrophy is
a consequence of many systemic diseases (e.g., cancer, diabetes,
renal failure) that can cause cell death (Lecker et al., 2004). It is
suspected that the underlying oxidative stress present in multiple
chronic diseases leads muscle fibers into a catabolic state and
subsequent wasting (Moylan and Reid, 2007).
ROS, MITOCHONDRIA, AND AGING
Mitochondria are viewed as one of the major contributors of
ROS production (Zuo et al., 2011b). In vivo experimentation has
confirmed that increased oxidative stress impairs mitochondrial
function (Williams et al., 1998; Berneburg et al., 1999). ROS can
also target proteins in the mitochondrial membrane and lead
to mitochondrial permeability transition (MPT) (Cosso et al.,
2002). ROS can contribute to the opening of the mitochondrial
permeability transition pore (mPTP) (Lemasters et al., 1998).
One such mechanism of ROS-mediated mPTP opening is by the
oxidation of dithiols in the protein pore located on the inner
mitochondrial membrane (Lemasters et al., 1998). The mPTP is
very sensitive to pathological conditions such as mitochondrial
autophagy, tissue ischemia, and infarction (Lemasters et al.,
1998, 2009). Prolonged mPTP opening causes the disruption
of osmotic balance that drives mitochondrial swelling and
ultimately leads to apoptotic or necrotic cell death (Table 1)
(Lemasters et al., 2009). This is physiologically significant in
photodynamic therapy in which targeted mitochondrial damage
leads to cancer cell apoptosis (Kowaltowski et al., 2009).
Interestingly, certain ROS (e.g., H2O2) affect mtDNA
more extensively than nuclear DNA (Berneburg et al., 1999).
Mitochondrial complexes I and III are the primary source of
O•−2 production (Babu et al., 2015). Due to the proximity
to mtDNA, higher levels of ROS production are associated
with more frequent mtDNA rearrangements (Esposito et al.,
1999; Kirkinezos and Moraes, 2001). Moreover, ·OH, the
product of H2O2 in Fenton reactions, may damage multiple
molecular structures including mtDNA (Kirkinezos and Moraes,
2001). The capability of mitochondria to produce cellular
energy is diminished with MPT, long-term fragmentation, and
accumulation of damaged mtDNA (Table 1) (Picard et al.,
2014). Oxidized mtDNA may also be released along with other
immunogenic molecules, further inducing inflammation and
modify gene expression (Picard et al., 2014).
Exercise-inducedmitochondrial biogenesis may lead to a wide
range of health benefits, including improved exercise tolerance,
oxidative capacity, and insulin resistance (Powers et al., 2011).
Mitochondrial biogenesis requires a synergistic effort between
both mitochondrial and nuclear genomes, as well as coordinated
responses from a variety of transcription factors and co-activators
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(Hood, 2001; Adhihetty et al., 2003; Powers et al., 2011).
Both peroxisome proliferator-activated receptor-γ (PPAR-γ) and
PGC-1α are actively involved in the regulation of mitochondrial
biogenesis (Irrcher et al., 2009; Powers et al., 2011). PGC-1α also
interacts with nuclear receptors and transcription factors that
upregulate genes, including estrogen-related receptor-α (ERR-α)
and myocyte enhance factor (MEF), contributing to organelle
synthesis (Powers et al., 2011).
The expression of PGC-1α is influenced by a variety of
stimuli that coincide with muscular exercise (Powers et al., 2011).
Intracellular redox status appears to significantly impact PGC-
1α activity (Powers et al., 2011). For instance, increased levels of
exogenous ROS have been shown to stimulate PGC-1α (Irrcher
et al., 2009), while the antioxidant N-acetyl cysteine may hinder
such activation (Powers et al., 2011). The PGC-1α promoter
contains transcription factor-binding sites such as activating
transcription factor 2, tumor suppressor gene p53, enhancer
box (EBox) proteins, MEF-2, and erythroid transcription factor
(GATA), many of which are ROS-sensitive (Powers et al.,
2011). Thus, exercised-induced elevation in ROS levels and the
subsequent PGC-1α activation may lead to the upregulation of
mitochondrial and nuclear DNA transcription factors (Figure 1).
ROS initiate degradative processes leading to oxidative stress
presented in the forms of modified proteins and nucleic acids
(Cadenas andDavies, 2000). These damaged cellular components
are then degraded by proteases or nucleases, ultimately leading to
oxidative stress-induced apoptosis (Cadenas and Davies, 2000).
These harmful events play a significant role in the aging process
(Table 1) (Cadenas and Davies, 2000). For instance, disruptions
in redox homeostasis are associated with aging in various tissues,
including skeletal muscle (Carter et al., 2007; Meng and Yu,
2010). Rats possess a reduced oxidative capacity in aging skeletal
muscle (Hepple et al., 2003). ROS are associated with sarcopenia,
defined as the loss of muscle mass and function (Shahar et al.,
2013). The incidence of sarcopenia is growing and affects 11–
50% of individuals over the age of 80 (von Haehling et al.,
2010). Systemic inflammation, diminished ability to respond to
stressors, and weakened regenerative capacity are all associated
with sarcopenia (Lightfoot et al., 2014). Restoring oxidative
balance may prevent or delay the onset of sarcopenia (Lightfoot
et al., 2014). For example, resveratrol reduces oxidative stress
in skeletal muscle (Jackson et al., 2010; Ryan et al., 2010).
However, resveratrol is ineffective in attenuating sarcopenia
(Jackson et al., 2011). Therefore, the mechanism underlying
the link between oxidative stress and sarcopenia remains
to be elucidated. Nonetheless, the aging process leads to a
decline of such redox-mediated adaptations essential for skeletal
muscle conditioning—contributing to age-related deterioration
(Jackson, 2011).
Impaired mitochondrial function and relative ROS increases
may occur in aging myocytes (Crescenzo et al., 2015).
Although acute increases in ROS can improve muscle contractile
endurance, long-term exposure to elevated amounts of ROS
provoke proteolysis and cell death in skeletal muscle (Powers
et al., 2010). Recent evidence indicates that ROS are involved in
apoptosis by oxidizing crucial cellular components (e.g., proteins,
nucleic acids, and lipids) (Barbieri and Sestili, 2012). ROS serve
as cellular intermediates in apoptosis by interfering with the
sarcoplasmic reticulum Ca2+ ion flux, resulting in the activation
of calpain and caspase-7 (Barbieri and Sestili, 2012). Moreover,
ROS can induce mitochondrial swelling and fragmentation,
facilitating the opening of mPTPs and the escape of proapoptotic
proteins (e.g., cytochrome c) (Table 1) (Barbieri and Sestili,
2012). ROS induce the release of apoptosis inducing factor (AIF)
and mitochondrial endonuclease G (Endo G), resulting in DNA
fragmentation in skeletal muscle (Table 1) (Barbieri and Sestili,
2012). Accordingly, Muller et al. suggested that the mechanism
underlying skeletal muscle atrophy is tightly associated with ROS
overproduction in the aging mitochondria (Muller et al., 2007).
REDOX IN NEUROMUSCULAR
DEGENERATION
Since neurons continuously generate free radicals, a sufficient
supply of endogenous antioxidants is necessary to maintain
homeostasis (Galea et al., 2012). Nerve cells are vulnerable
to the damaging effects of oxidative stress including the
oxidation of cytoskeletal proteins (Carletti et al., 2011). Oxidative
stress plays a significant role in neuromuscular diseases such
as amyotrophic lateral sclerosis (Barber et al., 2006; Fischer
et al., 2012). Deficiency in one of the major antioxidants,
Cu, Zn-superoxide dismutase (SOD1), may induce motor axon
degeneration (Table 1) (Fischer et al., 2011, 2012). Additionally,
the accumulation of very long chain fatty acids (VLCFA)
in neurodegenerative disorders may result in electron chain
impairment, thereby leading to ROS formation and lipid
peroxidation. One of the main neurodegenerative disorders
caused by VLCFA is the X-linked adrenoleukodystrophy (X-
ALD) (Kruska et al., 2015), associated with the loss of
peroxisomal ABCD1 fatty-acid transporter function and VLCFA
accumulation (Galea et al., 2012).
SKELETAL MUSCLE DYSFUNCTION
ROS are involved in the modulation of skeletal muscle
contractions (Zuo et al., 2014a, 2015b). However, excessive
oxidants promote muscle fatigue (Reid and Moylan, 2011).
Evidence has shown that muscle-derived oxidants are
significantly involved in tumor necrosis factor-α (TNF-α)-
related loss of force (Reid and Moylan, 2011; Zuo et al., 2014b).
Myofibrillar protein degradation, mediated by calpains and
caspases, may be activated by upstream factors including ROS
(Table 1) (Ochala et al., 2011). The overproduction of ROS,
via NOX activation, is also seen in diabetic skeletal muscle. In
particular, ROS-mediated glucose uptake may further contribute
to the elevated oxidative stress (Ebrahimian et al., 2006; Barbieri
and Sestili, 2012; Sinha et al., 2013). Additionally, ROS have been
implicated in the pathogenesis of muscular dystrophies such as
Duchenne muscular dystrophy (DMD) (Tidball and Wehling-
Henricks, 2007). Dystrophin is one of the major proteins
designed for the integrity of skeletal muscle fibers. Dysfunction
or absence of dystrophin molecules can cause muscular diseases
such as DMD, associated with necrosis of skeletal muscle fibers,
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as well as progressive muscular atrophy (Tidball and Wehling-
Henricks, 2007). There have been multiple studies that disclose
a link between ROS and DMD. For example, ROS can stimulate
the production of proinflammatory cytokines including TNF-α
and IL-1β through the activation of the NF-κB pathways (Malik
et al., 2012). These inflammatory cytokines are significantly
increased in dystrophic muscle cells immediately preceding
muscle fiber necrosis (Malik et al., 2012). ROS also interfere
with the functioning of RyR1. As such, nitrosylation of RyR1
receptors via NOS can increase the leakiness of sarcoplasmic
reticulum Ca2+ associated with muscular dystrophy (Table 1)
(Bellinger et al., 2009; Westerblad and Allen, 2011). ROS
oxidize sarcolemmal lipids or contractile proteins, contributing
to muscle dysfunction (Table 1) (Goldstein and Mcnally,
2010).
CONCLUSION
The research reviewed in this article has identified many of the
reactive species that affect skeletal muscle function. The pathways
mediated by ROS/RNS signaling have been discussed as well as
their role in skeletal muscle physiology. ROS have both beneficial
and harmful effects on skeletal muscle function as they are
ubiquitously involved in gene expression, immune responses,
mitochondrial oxidative stress, skeletal muscle atrophy, as well as
neuromuscular dystrophies. Redox-sensitive pathways continue
to be an area of much needed research. Such studies in the future
will shed significant insight into the exact role of ROS in health
and disease.
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